Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7F07

Autonomous VH domain that interacts with eIF4E at the Capped mRNA Binding site.

Summary for 7F07
Entry DOI10.2210/pdb7f07/pdb
DescriptorEukaryotic translation initiation factor 4E, VH domain (VH-DiFCAP-01) (3 entities in total)
Functional Keywordsinhibitor complex, cap-dependent translation, vh domain, rna binding protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight44240.74
Authors
Brown, C.J.,Frosi, Y.,Ng, S.,Lin, Y.C. (deposition date: 2021-06-03, release date: 2022-06-08, Last modification date: 2023-11-29)
Primary citationFrosi, Y.,Ng, S.,Lin, Y.C.,Jiang, S.,Ramlan, S.R.,Lama, D.,Verma, C.S.,Asial, I.,Brown, C.J.
Development of a novel peptide aptamer that interacts with the eIF4E capped-mRNA binding site using peptide epitope linker evolution (PELE).
Rsc Chem Biol, 3:916-930, 2022
Cited by
PubMed Abstract: Identifying new binding sites and poses that modify biological function are an important step towards drug discovery. We have identified a novel disulphide constrained peptide that interacts with the cap-binding site of eIF4E, an attractive therapeutic target that is commonly overexpressed in many cancers and plays a significant role in initiating a cancer specific protein synthesis program though binding the 5'cap (7'methyl-guanoisine) moiety found on mammalian mRNAs. The use of disulphide constrained peptides to explore intracellular biological targets is limited by their lack of cell permeability and the instability of the disulphide bond in the reducing environment of the cell, loss of which results in abrogation of binding. To overcome these challenges, the cap-binding site interaction motif was placed in a hypervariable loop on an VH domain, and then selections performed to select a molecule that could recapitulate the interaction of the peptide with the target of interest in a process termed Peptide Epitope Linker Evolution (PELE). A novel VH domain was identified that interacted with the eIF4E cap binding site with a nanomolar affinity and that could be intracellularly expressed in mammalian cells. Additionally, it was demonstrated to specifically modulate eIF4E function by decreasing cap-dependent translation and cyclin D1 expression, common effects of eIF4F complex disruption.
PubMed: 35866173
DOI: 10.1039/d2cb00099g
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.25 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon